Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in crohn’s disease

European Journal of Gastroenterology and Hepatology

Volumn 13, Issue 2, 2001, Pages 101-106

  Lomer, Miranda C E ^a   Harvey, Rory S J ^a   Evans, Stephen M ^a   Thompson, Richard P H ^a   Powell, Jonathan J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Crohn s disease; Diet; Microparticles; Ultrafine particles

Indexed keywords

CORTICOSTEROID;

ADULT; ANTIGENICITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DIET RESTRICTION; DIET THERAPY; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; FEMALE; FOOD CONTAMINATION; HUMAN; INTESTINE LYMPHATIC TISSUE; MALE; PARTICULATE MATTER; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALUMINUM SILICATES; CROHN DISEASE; DIET; DOUBLE-BLIND METHOD; FEMALE; FOOD CONTAMINATION; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TITANIUM;

EID: 0035138359     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/00042737-200102000-00003     Document Type: Article

References (34)

1. Okada M, Yao T, Yammamoto K, Takenaka K, Imamura K, Maeda K. et al. Controlled trial comparing an elemental diet with prednisolone in the treatment of active Crohn’s disease. Hepatogastroenterology 1990; 37: 72-80.
2. O’Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn’s disease: a controlled trial. BMJ 1984; 288: 1859-1862.
3. Zoli G, Care M, Parazza M, Spano C, Biagi PL, Bernardi M. et al. A randomized controlled study comparing elemental diet and steroid treatment in Crohn’s disease. Aliment Pharmacol Ther 1997; 11: 735-740.
4. Goode A, Hawkins T, Feggetter JGW, Johnston JDA. Use of elemental diet for long term nutritional support in Crohn’s disease. Lancet 1976; 1: 122-124.
5. Dieleman LA, Heizer WD. Nutrition issues in inflammatory bowel disease. Gastroenterol Clin North Am 1998; 27: 435-451.
6. Reif S, Klein I, Lubin M, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 754-760.
7. Powell JJ, Ainley CC, Harvey RSJ, Mason IM, Kendall MD, Sankley EA. et al. Characterisation of inorganic microparticles in pigment cells of human gut associated lymphoid tissue. Gut 1996; 38: 390-395.
8. Price EW. Podoconiosis: Non-filarial Elephantiasis. Oxford: Oxford University Press; 1990.
9. Delfino RJ, Becklake MR, Hanley JA. The relationship of urgent hospital admissions for respiratory illnesses to photochemical air pollution levels in Montreal. Environ Res 1994; 67: 1-19.
10. Peters A, Wichmann HE, Tuch T, Heinrich J, Heyder J. Respiratory effects are associated with the number of ultra-fine particles. Am J Respir Crit Care Med 1997; 155: 1376-1383.
11. Schwartz J, Slater D, Larson TV, Pierson WE, Koenig JQ. Particulate air pollution and hospital emergency room visits for asthma in Seattle. Am Rev Respir Dis 1993; 147: 826-831.
12. Powell JJ, Harvey RSJ, Ashwood P, Wolstencroft R, Gershwin ME, Thompson RPH. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmunity 2000; 14: 99-105.
13. Lee KP, Trochimowicz HJ, Reinhardt CF. Pulmonary responses of rats exposed to titanium dioxide by inhalation for two years. Toxicol Appl Pathol 1985; 79: 179-182.
14. Ashwood P, Evans SM, Berisha F, Walker-Nthenda L, Thompson RPH, Powell JJ. Lipopolysaccharide (LPS) adsorbed to inorganic dietary particles hyperstimulates intestinal mononuclear cells. Gut 1999; 44 (suppl 1): A92. A92.
15. Best WR, Becktel JM, Singleton JW, Kern F. Development of a Crohn’s disease activity index: National Cooperative Crohn’s Disease Study. Gastroenterology 1976; 70: 439-444.
16. McWhirter JP, Pennington CR. Incidence and recognition of malnutrition in hospital. BMJ 1994; 308: 945-948.
17. Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. Report on health and social subjects number 41. London: HMSO; 1991.
18. Holland B, Welch AA, Unwin ID, Buss DH, Paul AA, Southgate DAT. McCance and Widdowson’s: The Composition of Foods. London: Royal Society of Chemistry; 1991.
19. Ballegaard M, Bjergstrom A, Brondum S, Hylander E, Jensen L, Ladefoged K. Self-reported food intolerance in chronic inflammatory bowel disease. Scand J Gastroenterol 1997; 32: 569-571.
20. Yacyshyn BR, Bowen-Yacyshyn MB, Jewell L, Tami JA, Bennett CF, Kisner DL. et al. A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn’s disease. Gastroenterology 1998; 114: 1133-1142.
21. Gross V, Andus T, Ecker KW, Raedler A, Loeschke K, Plauth M. et al. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn’s disease. Gut 1998; 42: 493-496.
22. Ministry of Agriculture Fisheries and Food. Dietary Intake of Food Additives in the UK: Initial Surveillance. Food Surveillance, Paper No. 37. London: HMSO; 1993.
23. Churg A. The uptake of mineral particles by pulmonary epithelial cells. Am J Respir Crit Care Med 1996; 154: 1124-1140.
24. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 1993; 90: 4942-4946.
25. Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, Rock KL. Analysis of MHC class II presentation of particulate antigens by B lymphocytes. J Immunol 1996; 156: 2809-2818.
26. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn’s disease. J Pediatr Gastroenterol Nutr 1993; 17: 75-81.
27. Teahon K, Pearson M, Levi AJ, Bjarnason I. Practical aspects of elemental diet in the management of patients with Crohn’s disease. Gastroenterology 1991; 100: A256. A256.
28. Malchow H, Steinhardt HJ, Lorenz-Meyer H, Strohm WD, Rasmussen S, Sommer H. et al. Feasibility and effectiveness of a defined formula diet regimen in treating active Crohn’s disease.: European Co-operative Crohn’s disease study III. Scand J Gastroenterol 1990; 25: 235-244.
29. Fernandez-Banares F, Cabre E, Gonzalez-Huix F, Gaussull MA. Enteral nutrition as primary therapy in Crohn’s disease. Gut 1994; 35 (suppl 1): S55-S59.
30. Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, Newmark H. et al. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 1998; 280: 1074-1079.
31. Lapré JA, De Vries HT, Termont DSML, Kleibeuker JH, De Vries EGE, Van der Meer R. Mechanism of the protective effect of supplemental dietary calcium on cytolytic activity of fecal water. Cancer Res 1993; 53: 248-253.
32. Slattery ML, Sorenson AW, Ford MH. Dietary calcium intake as a mitigating factor in colon cancer. Am J Epidemiol 1988; 128: 504-514.
33. Powell JJ, Whitehead MW, Ainley CC, Kendall MD, Nicholson JK, Thompson RPH. Dietary minerals in the gastrointestinal tract: hydroxypolymerisation of aluminium is regulated by luminal mucins. J Inorg Biochem 1999; 75: 167-180.
34. Ellingsen JE. A study on the mechanism of protein adsorption to TiO2. Biomaterials 1991; 12: 593-596.